Doximity, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-60.0% vs price
Base Case (Median)
-42.3% vs price
Bull Case (75th pct.)
3.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $3.09 | -87.4% | High (40%) |
| PE Comparable | $18.92 | -22.9% | Medium (25%) |
| Growth Trajectory DCF | $70.73 | 188.5% | Medium (20%) |
| Graham Number | $9.86 | -59.8% | Medium (40%) |
| EV/EBITDA | $14.14 | -42.3% | Medium (20%) |
| EV/FCF | $32.01 | 30.5% | Medium (20%) |
| Earnings Power Value | $9.78 | -60.1% | Medium (50%) |
Based on 7 out of 8 methods, DOCS appears fairly valued at the current price of $24.52. The base case fair value of $14.14 implies 42.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.